EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Oncologic and fertility outcomes in patients with pure ovarian immature teratoma and gliomatosis peritonei: a single-center experience

Pengrui Tang, Dan Wang, Congwei Jia, Yao Wei, Jiaxin Yang, Jie Yang, Peng Peng, Dongyan Cao, Junjun Yang, Yang Xiang

Archives of Gynecology and Obstetrics · 20.10.2026

DOI: 10.1007/s00404-026-08597-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Gynecology and Obstetrics, online erschienen am 20.10.2026. Verfasst von Pengrui Tang und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gliomatosis peritonei (GP) is a rare condition characterized by peritoneal implants of mature glial tissue, often associated with ovarian immature teratoma (IMT). Because of its rarity, very few studies have focused on the outcomes of GP. This study aimed to describe the clinical outcomes of patients with pure IMT and GP.

Methods

We retrospectively reviewed the clinicopathological data for 38 patients with pure IMT and GP at a single center between January 2000 and December 2024.

Results

Twenty-five (65.8%), seven (18.4%), and six (15.8%) of the 38 patients were International Federation of Gynecology and Obstetrics stages I, II, III, respectively, with 11 (28.9%), 13 (34.2%), and 14 (36.8%) being grade 1, 2, and 3, respectively. The median age at diagnosis was 22.5 years (range 9–41 years). Fertility-sparing surgery was performed in 35 (92.1%) patients. Thirty patients (78.9%) received postoperative adjuvant chemotherapy. Fifteen patients experienced recurrence during a median follow-up duration of 88 months (range 11–268 months), including mature teratoma recurrence in 12 and IMT recurrence in 3. All patients underwent successful salvage therapy, except for one death. Ten of 11 patients who attempted conception subsequently had successful pregnancies, resulting in a total of 13 live births. By the end of follow-up, 34 patients were alive without disease, three were alive with disease without symptoms, and one patient had died of disease progression after relapse.

Conclusions

Patients with IMT and GP exhibit a favorable overall prognosis. GP may remain clinically indolent and asymptomatic for a long period. Reproductive outcomes are promising.

Zitieren

APA

Tang, P., Wang, D., Jia, C., Wei, Y., Yang, J., Yang, J., Peng, P., Cao, D., Yang, J., & Xiang, Y. (2026). Oncologic and fertility outcomes in patients with pure ovarian immature teratoma and gliomatosis peritonei: a single-center experience. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-026-08597-8

Vancouver

Tang P, Wang D, Jia C, Wei Y, Yang J, Yang J, et al. Oncologic and fertility outcomes in patients with pure ovarian immature teratoma and gliomatosis peritonei: a single-center experience. Archives of Gynecology and Obstetrics. 2026. doi:10.1007/s00404-026-08597-8

BibTeX
@article{Tang2026,
  author = {Tang, Pengrui and Wang, Dan and Jia, Congwei and Wei, Yao and Yang, Jiaxin and Yang, Jie and Peng, Peng and Cao, Dongyan and Yang, Junjun and Xiang, Yang},
  title = {Oncologic and fertility outcomes in patients with pure ovarian immature teratoma and gliomatosis peritonei: a single-center experience},
  journal = {Archives of Gynecology and Obstetrics},
  year = {2026},
  doi = {10.1007/s00404-026-08597-8}
}
Kostenlos starten →